Choi et al., 2015 - Google Patents
Lack of association between DRD2 Taq1A gene polymorphism and smoking cessation therapy: a meta-analysisChoi et al., 2015
- Document ID
- 9706575357245186084
- Author
- Choi H
- Shin W
- Publication year
- Publication venue
- International journal of clinical pharmacology and therapeutics
External Links
Snippet
Recent studies have reported that genetic factors are significantly associated with smoking behavior, but the influence of the smoking behavior-related genes on smoking cessation treatment is still not clear. We analyzed the smoking cessation outcomes among previously …
- 230000005586 smoking cessation 0 title abstract description 23
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Morgensztern et al. | Molecularly targeted therapies in non–small-cell lung cancer annual update 2014 | |
| Wood et al. | Molecular histology of lung cancer: from targets to treatments | |
| Ma et al. | Pharmacogenetics, pharmacogenomics, and individualized medicine | |
| Dupaul-Chicoine et al. | The Nlrp3 inflammasome suppresses colorectal cancer metastatic growth in the liver by promoting natural killer cell tumoricidal activity | |
| Cheng et al. | MeCP2: multifaceted roles in gene regulation and neural development | |
| WO2012174338A3 (en) | Method of selecting therapeutic indications | |
| WO2019090347A8 (en) | Adenosine pathway inhibitors for cancer treatment | |
| SG195191A1 (en) | Methods and compositions of predicting activity of retinoid x receptor modulator | |
| WO2007143752A3 (en) | Targets in breast cancer for prognosis or therapy | |
| WO2014022826A3 (en) | Biomarker associated with risk of melanoma reoccurrence | |
| WO2008088854A3 (en) | Genetic markers for predicting responsiveness to combination therapy | |
| WO2014145751A3 (en) | Targeted therapies for cancer | |
| HK1248133A1 (en) | Methods for treating neuroblastoma | |
| Choi et al. | Effects of ACE and ADD1 gene polymorphisms on blood pressure response to hydrochlorothiazide: a meta-analysis | |
| WO2013056087A3 (en) | Compositions and methods for treating and preventing coronary heart disease | |
| BR112014027905A2 (en) | antibody, cell, nucleic acid, methods of identifying a first antibody, inhibiting cell growth, therapeutic treatment, determining the presence of a protein, diagnosing a tumor, and delivering a cytotoxic agent. | |
| Choi et al. | Lack of association between DRD2 Taq1A gene polymorphism and smoking cessation therapy: a meta-analysis | |
| Szklarczyk et al. | Opioid-dependent regulation of high and low fear responses in two inbred mouse strains | |
| Ó'Léime et al. | The orphan nuclear receptor TLX regulates hippocampal transcriptome changes induced by IL-1β | |
| Poznanski et al. | Delta-opioid receptor antagonism leads to excessive ethanol consumption in mice with enhanced activity of the endogenous opioid system | |
| WO2012109233A3 (en) | Methods for predicting recurrence risk in breast cancer patients | |
| WO2011066082A3 (en) | Markers associated with ribavirin-induced anemia | |
| MX2009008788A (en) | Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of death. | |
| Ye et al. | USF1 gene polymorphisms may associate with the efficacy and safety of chemotherapy based on paclitaxel and prognosis in the treatment of ovarian cancer | |
| WO2012129395A3 (en) | Diagnosis and treatment of prostate cancer |